SCHEMBL5677176

SCHEMBL5677176

CCCCC(CC)CC(=Cc1ccc(OC)cc1)C(=O)O.CCCCCCCCC(=Cc1ccc(OC)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
ALOX5 P09917 2/20 0.44
APEX1 P27695 3/20 0.43
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
CNR1 P21554 3/20 0.40
PPARG P37231 2/20 0.40
PTGES O14684 1/20 0.40
FFAR1 O14842 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
MMP1 P03956 2/20 0.38
MMP2 P08253 2/20 0.38
MMP3 P08254 2/20 0.38
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17627791 0.93 TDP1 (0.56) TDP1ALOX5TAS1R3TAS1R1MMP1
SCHEMBL5198950 0.93 TDP1 (0.56) TDP1ALOX5TAS1R3TAS1R1MMP1
SCHEMBL126604 0.93 TDP1 (0.56) TDP1ALOX5TAS1R3TAS1R1MMP1
SCHEMBL39941 0.87 APEX1 (0.53) TDP1ALOX5APEX1CNR1PPARG
SCHEMBL2489081 0.87 APEX1 (0.53) TDP1ALOX5APEX1CNR1PPARG
SCHEMBL9301856 0.87 APEX1 (0.53) TDP1ALOX5APEX1CNR1PPARG
4-Methoxycinnamic Acid SCHEMBL1548518 0.86 TDP1 (0.60) TDP1TAS1R3TAS1R1THRB
SCHEMBL2490383 0.86 ALOX5 (0.54) TDP1ALOX5APEX1CNR1PPARG
SCHEMBL7181298 0.86 TDP1 (0.42) TDP1ALOX5TAS1R3TAS1R1CNR1
Octinoxate SCHEMBL29435124 0.84 TDP1 (0.76) TDP1ALOX5TAS1R3TAS1R1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3257497-B1 ANTIOXIDANT AGENT, ANTIOXIDANT COSMETIC AND UV CARE COSMETIC BASED ON ENZYMATICALLY SYNTHESIZED GLYCOGEN OR AN ALPHA-AMYLASE DIGEST THEREOF EZAKI GLICO CO (JP) 2024-04-24 EP disclosed
EP-4356897-A1 POWDER COSMETIC AND PRODUCTION METHOD FOR SAME Shiseido Company, Ltd. (JP) 2024-04-24 EP disclosed
WO-2023190190-A1 OILY COMPOSITION AND COSMETIC PREPARATION 日清オイリオグループ株式会社 2023-10-05 WO disclosed
US-10286005-B2 Antioxidant agent, and antioxidant cosmetic and UV care cosmetic EZAKI GLICO CO., LTD. (JP) 2019-05-14 US disclosed
US-20180000856-A1 ANTIOXIDANT AGENT, AND ANTIOXIDANT COSMETIC AND UV CARE COSMETIC EZAKI GLICO CO., LTD. (JP) 2018-01-04 US disclosed
EP-3257497-A1 ANTIOXIDANT AGENT, AND ANTIOXIDANT COSMETIC AND UV CARE COSMETIC Ezaki Glico Co., Ltd. (JP) 2017-12-20 EP disclosed
US-20120201775-A1 HAIR STYLING COSMETIC SHISEIDO COMPANY LTD. (JP) 2012-08-09 US disclosed
EP-2468244-A1 HAIR-DRESSING COSMETIC Shiseido Company, Ltd. (JP) 2012-06-27 EP disclosed
US-20060257436-A1 Skin preparation composition for external use SHISEIDO COMPANY, LTD. (JP) 2006-11-16 US disclosed
EP-1614351-A1 SKIN PREPARATION COMPOSITION FOR EXTERNAL USE SHISEIDO COMPANY, LTD. (JP) 2006-01-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060257436-A1 Skin preparation composition for external use CUTA, KRT18, CYP24A1 TDP1 2996/4885ALOX5 1411/4885APEX1 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.